CFM
ZBH icon

Catalyst Funds Management’s Zimmer Biomet ZBH Stock Holding History

Catalyst Funds Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Buy
+3,000
New +$263K 0.01% 527
2025
Q1 		– Sell
-2,200
Closed -$232K – 605
2024
Q4 		$232K Buy
+2,200
New +$236K 0.06% 238
2024
Q3 		– Sell
-100
Closed -$10.9K – 1639
2024
Q2 		$10.9K Buy
+100
New +$11.8K ﹤0.01% 895

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Catalyst Funds Management's ZBH Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 3,000 shares worth $258K. The stake represents 0.01% of the portfolio and ranks #527 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in ZBH as recently as Q4 2024.

Catalyst Funds Management first reported a position in ZBH in Q2 2024 and has held it in 3 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Catalyst Funds Management held 3,000 shares of Zimmer Biomet worth $258K as of Q2 2026.
  • Zimmer Biomet was a new Catalyst Funds Management position in Q2 2026.
  • Zimmer Biomet made up 0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #527 holding.
  • Catalyst Funds Management first reported a position in Zimmer Biomet in Q2 2024 and has held it in 3 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.